Bone Marrow Transplant Market Analysis

Transplant Type (Autologous and Allogeneic)

By the end of 2037, autologous segment is estimated to dominate around 56.4% bone marrow transplant market share. The growth can be attributed to the rising adoption of autologous transplant procedures due to their reduced risk of immune rejection and complications. A 2023 published report on autologous stem cell transplantation published by the American Society for Transplantation and Cellular Therapy (ASTCT), reported that 20% to 50% of patients with multiple myeloma undergo autologous stem cell transplantation. The autologous type of transplant uses the patient’s stem cells, which are harvested before high-dose treatments like chemotherapy, and then reinfused after treatment to help restore bone marrow. Improved techniques in stem cell harvesting and storage have made the autologous transplant procedure more accessible, encouraging more patients and healthcare providers to consider it as a viable treatment.

Moreover, autologous transplants generally incur lower healthcare costs compared to allogeneic transplants due to fewer complications and no need for donor match. This cost benefit is driving adoption in healthcare systems focused on reducing overall treatment costs.

End user (Hospitals, Multispecialty Clinics, and Ambulatory Surgical Centers)

In bone marrow transplant market, hospital segment is poised to account for more than 92.2% revenue share by the end of 2037. The growth can be attributed to the rising demand for specialized, high-quality care for such complex procedures. Hospitals hold a substantial share of the bone marrow transplant market, especially large, well-equipped medical centers with dedicated oncology and hematology departments.

Hospitals, especially large and specialized institutions, account for a significant share of bone marrow transplants due to the need for advanced technology and 24/7 medical teams to monitor patients before, during, and after the procedure. There are approximately 200 medical centers (hospitals) that perform transplants in the U.S. Globally, the number of bone marrow transplants conducted each year is increasing. In 2021, 4,276 related and 5,073 unrelated bone marrow and cord blood transplants were performed in the U.S., according to the Center for International Blood and Marrow Transplant Research.

Our in-depth analysis of the bone marrow transplant market includes the following segments: